Search results for "Highlights"
U.S. sees increase in alcohol-associated liver disease mortality
Deaths from alcohol-associated liver disease increased among men and women, across all ages, and in all racial/ethnic populations in the U.S. from 2017 through 2020, leading researchers to call for a nationwide effort to reduce national alcohol consumption, improve screening, and optimize early treatment.
https://gastroenterology.acponline.org/archives/2022/03/25/2.htm
25 Mar 2022
Guideline recommends multiple drug classes to treat adults with moderate to severe luminal, fistulizing Crohn's disease
A new clinical practice guideline from the American Gastroenterological Association offered recommendations on which drug classes to use for induction and maintenance of remission, as well as some combination therapies.
https://gastroenterology.acponline.org/archives/2021/06/25/2.htm
25 Jun 2021
Bentonite hemostatic powder noninferior to standard care for GI bleeding
In a single-blind randomized controlled trial, bleeding was controlled within 30 days in 90.1% of adults with acute nonvariceal bleeding on upper GI endoscopy assigned to receive TC-325 versus 81.4% of those assigned to standard treatment.
https://gastroenterology.acponline.org/archives/2021/12/17/3.htm
17 Dec 2021
Urinary biomarker may help predict cirrhosis outcomes, study finds
Levels of urine liver fatty acid-binding protein could be used together with Model for End-stage Liver Disease scoring to improve predictions of liver failure or death, according to an analysis of patients hospitalized for decompensated cirrhosis.
https://gastroenterology.acponline.org/archives/2021/09/24/3.htm
24 Sep 2021
Spotlight on PPIs and cancer
Recent studies assessed the association between proton-pump inhibitors (PPIs) and cancer, as well as the effects of PPI treatment after a cancer diagnosis.
https://gastroenterology.acponline.org/archives/2021/07/23/5.htm
23 Jul 2021
Severe COVID-19 associated with more IBS, less constipation
A prospective multicenter study found that patients hospitalized for COVID-19 had significantly higher rates of irritable bowel syndrome (IBS) and fewer problems with constipation at 12 months than controls.
https://gastroenterology.acponline.org/archives/2022/12/23/1.htm
23 Dec 2022
Spotlight on COVID-19 vaccines in IBD
Recent research looked at the response to mRNA COVID-19 vaccines among patients with inflammatory bowel disease (IBD), as well as examined COVID-19 vaccine uptake and offered ways to address vaccine hesitancy in this population.
https://gastroenterology.acponline.org/archives/2021/10/22/5.htm
22 Oct 2021
Transportation, patient education among factors affecting colonoscopy rates after abnormal FIT, survey finds
Primary care physicians and staff were asked to identify patients' barriers to completing colonoscopy after an abnormal fecal immunochemical test (FIT) result, as well as factors that made completion more likely.
https://gastroenterology.acponline.org/archives/2021/08/27/2.htm
27 Aug 2021
Half of overweight, obese adults may have fatty liver disease
The global prevalence of metabolic dysfunction-associated fatty liver disease, a newly proposed term for nonalcoholic fatty liver disease, is “astonishingly high,” the authors of a recent meta-analysis found.
https://gastroenterology.acponline.org/archives/2021/02/26/3.htm
26 Feb 2021
NAFLD progression associated with increased mortality risk
Patients with stage F4 nonalcoholic fatty liver disease (NAFLD) have significantly increased risk for liver-related complications, type 2 diabetes, and all-cause mortality compared to those with earlier stages, an observational prospective study found.
https://gastroenterology.acponline.org/archives/2021/10/22/3.htm
22 Oct 2021